Skip to content
Open in App
Artgen logo

Artgen

web2

Artgen Biotech is a Russian biotechnology company that develops biomedical treatments, diagnost...

Symbol ยท ABIO
Company profile

About

Artgen Biotech is a Russian biotechnology company that develops biomedical treatments, diagnostic technologies, medical devices, and related healthcare services through a portfolio of research and operating businesses. Its development areas include vaccines, antibodies, gene therapies, and regenerative medicine technologies, with projects at differing stages of research and clinical use. Artgen also works in medical genetics, biological sample storage, and cell-based services through businesses in its ecosystem. The group invests in and helps commercialize healthcare technologies rather than operating solely as a single-product drug developer. Formerly known as the Human Stem Cell Institute, its shares trade on the Moscow Exchange under ABIO.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeMoscowPrimary symbol: ABIO
Expert coverage

Artgen profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment